April 16, 2019
Mitsubishi Tanabe Pharma said on April 15 that Chinese authorities accepted its application filing for Radicut (edaravone) for approval review for the treatment of amyotrophic lateral sclerosis (ALS) as of April 3. Radicut, otherwise known as Radicava, is believed to...read more